Intended for healthcare professionals


Hypocalcaemia after intravenous bisphosphonate

BMJ 2004; 328 doi: (Published 10 June 2004) Cite this as: BMJ 2004;328:1439

Lesson to be learnt

  1. Cameron Fergus, specialist registrar in palliative medicine (
  1. Royal Infirmary of Edinburgh, Edinburgh EH3 9YW

    EDITOR—Peter et al discuss the risk of hypocalcaemia after intravenous bisphosphonate.1 Case 4 of their series provides the opportunity for a further lesson to be learnt.

    The patient in this case was given 90 mg pamidronate as treatment for hypercalcaemia of malignancy. A further 60 mg was …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription